Búsqueda | Portal de Búsqueda de la BVS España

1.

Follow-up of patients with R/R FLT3-mutation-positive AML treated with gilteritinib in the phase 3 ADMIRAL trial.

Perl, Alexander E; Larson, Richard A; Podoltsev, Nikolai A; Strickland, Stephen; Wang, Eunice S; Atallah, Ehab; Schiller, Gary J; Martinelli, Giovanni; Neubauer, Andreas; Sierra, Jorge; Montesinos, Pau; Récher, Christian; Yoon, Sung-Soo; Hosono, Naoko; Onozawa, Masahiro; Chiba, Shigeru; Kim, Hee-Je; Hasabou, Nahla; Lu, Qiaoyang; Tiu, Ramon; Levis, Mark J.

Blood; 139(23): 3366-3375, 2022 06 09.

Artículo en Inglés | MEDLINE | ID: mdl-35081255

2.

[Future prospects for the development of novel agents for acute myeloid leukemia].

Hosono, Naoko.

Rinsho Ketsueki; 65(5): 353-361, 2024.

Artículo en Japonés | MEDLINE | ID: mdl-38825514

3.

Clinical utility of genomic profiling of AML using paraffin-embedded bone marrow clots: HM-SCREEN-Japan 01.

Hosono, Naoko; Chi, SungGi; Yamauchi, Takahiro; Fukushima, Kentaro; Shibayama, Hirohiko; Katagiri, Seiichiro; Gotoh, Akihiko; Eguchi, Motoki; Morishita, Takanobu; Ogasawara, Reiki; Kondo, Takeshi; Yanada, Masamitsu; Yamamoto, Kazuhito; Kobayashi, Tsutomu; Kuroda, Junya; Usuki, Kensuke; Utsu, Yoshikazu; Yoshimitsu, Makoto; Ishitsuka, Kenji; Ono, Takaaki; Takahashi, Naoto; Iyama, Satoshi; Kojima, Kensuke; Nakamura, Yukinori; Fukuhara, Suguru; Izutsu, Koji; Abutani, Hikaru; Yamauchi, Nobuhiko; Yuda, Junichiro; Minami, Yosuke.

Cancer Sci; 114(5): 2098-2108, 2023 May.

Artículo en Inglés | MEDLINE | ID: mdl-36793248

4.

Phase I study of alvocidib plus cytarabine/mitoxantrone or cytarabine/daunorubicin for acute myeloid leukemia in Japan.

Ikezoe, Takayuki; Ando, Kiyoshi; Onozawa, Masahiro; Yamane, Takahisa; Hosono, Naoko; Morita, Yasuyoshi; Kiguchi, Toru; Iwasaki, Hiromi; Miyamoto, Toshihiro; Matsubara, Keisuke; Sugimoto, Saori; Miyazaki, Yasushi; Kizaki, Masahiro; Akashi, Koichi.

Cancer Sci; 113(12): 4258-4266, 2022 Dec.

Artículo en Inglés | MEDLINE | ID: mdl-35689544

5.

Gilteritinib or Chemotherapy for Relapsed or Refractory FLT3-Mutated AML.

Perl, Alexander E; Martinelli, Giovanni; Cortes, Jorge E; Neubauer, Andreas; Berman, Ellin; Paolini, Stefania; Montesinos, Pau; Baer, Maria R; Larson, Richard A; Ustun, Celalettin; Fabbiano, Francesco; Erba, Harry P; Di Stasi, Antonio; Stuart, Robert; Olin, Rebecca; Kasner, Margaret; Ciceri, Fabio; Chou, Wen-Chien; Podoltsev, Nikolai; Recher, Christian; Yokoyama, Hisayuki; Hosono, Naoko; Yoon, Sung-Soo; Lee, Je-Hwan; Pardee, Timothy; Fathi, Amir T; Liu, Chaofeng; Hasabou, Nahla; Liu, Xuan; Bahceci, Erkut; Levis, Mark J.

N Engl J Med; 381(18): 1728-1740, 2019 10 31.

Artículo en Inglés | MEDLINE | ID: mdl-31665578

6.

Mutated KIT Tyrosine Kinase as a Novel Molecular Target in Acute Myeloid Leukemia.

Katagiri, Seiichiro; Chi, SungGi; Minami, Yosuke; Fukushima, Kentaro; Shibayama, Hirohiko; Hosono, Naoko; Yamauchi, Takahiro; Morishita, Takanobu; Kondo, Takeshi; Yanada, Masamitsu; Yamamoto, Kazuhito; Kuroda, Junya; Usuki, Kensuke; Akahane, Daigo; Gotoh, Akihiko.

Int J Mol Sci; 23(9)2022 Apr 23.

Artículo en Inglés | MEDLINE | ID: mdl-35563085

7.

[Hematopoietic cell transplantation for FLT3-mutated acute myeloid leukemia].

Hosono, Naoko.

Rinsho Ketsueki; 63(9): 1242-1251, 2022.

Artículo en Japonés | MEDLINE | ID: mdl-36198550

8.

Characterization of newly established Pralatrexate-resistant cell lines and the mechanisms of resistance.

Oiwa, Kana; Hosono, Naoko; Nishi, Rie; Scotto, Luigi; O'Connor, Owen A; Yamauchi, Takahiro.

BMC Cancer; 21(1): 879, 2021 Jul 31.

Artículo en Inglés | MEDLINE | ID: mdl-34332580

9.

Gilteritinib versus chemotherapy in Japanese patients with FLT3-mutated relapsed/refractory acute myeloid leukemia.

Hosono, Naoko; Yokoyama, Hisayuki; Aotsuka, Nobuyuki; Ando, Kiyoshi; Iida, Hiroatsu; Ishikawa, Takayuki; Usuki, Kensuke; Onozawa, Masahiro; Kizaki, Masahiro; Kubo, Kohmei; Kuroda, Junya; Kobayashi, Yukio; Shimizu, Takayuki; Chiba, Shigeru; Nara, Miho; Hata, Tomoko; Hidaka, Michihiro; Fujiwara, Shin-Ichiro; Maeda, Yoshinobu; Morita, Yasuyoshi; Kusano, Mikiko; Lu, Qiaoyang; Miyawaki, Shuichi; Berrak, Erhan; Hasabou, Nahla; Naoe, Tomoki.

Int J Clin Oncol; 26(11): 2131-2141, 2021 Nov.

Artículo en Inglés | MEDLINE | ID: mdl-34363558

10.

[Lineage switch from T-lymphoblastic leukemia to myeloid leukemia at relapse].

Kuze, Ayaka; Ida, Naoko; Hosono, Naoko; Negoro, Eiju; Yamauchi, Takahiro.

Rinsho Ketsueki; 62(7): 721-726, 2021.

Artículo en Japonés | MEDLINE | ID: mdl-34349054

11.

Venetoclax and alvocidib are both cytotoxic to acute myeloid leukemia cells resistant to cytarabine and clofarabine.

Nishi, Rie; Shigemi, Hiroko; Negoro, Eiju; Okura, Miyuki; Hosono, Naoko; Yamauchi, Takahiro.

BMC Cancer; 20(1): 984, 2020 Oct 12.

Artículo en Inglés | MEDLINE | ID: mdl-33046037

12.

Genetic abnormalities and pathophysiology of MDS.

Hosono, Naoko.

Int J Clin Oncol; 24(8): 885-892, 2019 Aug.

Artículo en Inglés | MEDLINE | ID: mdl-31093808

13.

[Genetic defects of chromosome 5q and 7q in myeloid neoplasms].

Hosono, Naoko.

Rinsho Ketsueki; 60(7): 800-809, 2019.

Artículo en Japonés | MEDLINE | ID: mdl-31391370

14.

[New therapeutic agents for acute myeloid leukemia].

Hosono, Naoko.

Rinsho Ketsueki; 60(9): 1108-1119, 2019.

Artículo en Japonés | MEDLINE | ID: mdl-31597834

15.

Hematopoietic status of the whole-body bone marrow in hypoplastic acute promyelocytic leukemia as evaluated by ¹⁸F-FLT PET/MRI.

Araie, Hiroaki; Tasaki, Toshiki; Hosono, Naoko; Tsujikawa, Tetsuya; Okazawa, Hidehiko; Yamauchi, Takahiro.

Ann Hematol; 102(7): 1957-1959, 2023 07.

Artículo en Inglés | MEDLINE | ID: mdl-37150795

16.

Infectious complications in adults undergoing intensive chemotherapy for acute myeloid leukemia in 2001-2005 using the Japan Adult Leukemia Study Group AML201 protocols.

Kato, Hideaki; Fujita, Hiroyuki; Akiyama, Nobu; Kimura, Shun-Ichi; Hiramoto, Nobuhiro; Hosono, Naoko; Takahashi, Tsutomu; Shigeno, Kazuyuki; Minamiguchi, Hitoshi; Miyatake, Junichi; Handa, Hiroshi; Kanda, Yoshinobu; Yoshida, Minoru; Miyawaki, Shuichi; Ohtake, Shigeki; Naoe, Tomoki; Kiyoi, Hitoshi; Matsumura, Itaru; Miyazaki, Yasushi.

Support Care Cancer; 26(12): 4187-4198, 2018 Dec.

Artículo en Inglés | MEDLINE | ID: mdl-29860713

17.

[Evaluation of Chemotherapy-Induced Nausea and Vomiting in Patients with Hematological Malignancies Using MASCC Antiemesis Tool(MAT)].

Oiwa, Kana; Hosono, Naoko; Itoh, Kazuhiro; Ookura, Miyuki; Matsuda, Yasufumi; Tai, Katsunori; Ueda, Takanori; Yamauchi, Takahiro.

Gan To Kagaku Ryoho; 45(1): 45-50, 2018 Jan.

Artículo en Japonés | MEDLINE | ID: mdl-29362306

18.

An eltrombopag-induced remission of bone-marrow aplasia accompanied by marked leukoerythroblastosis and splenomegaly.

Arita, Kotaro; Murakami, Jun; Iwaki, Noriko; Hosono, Naoko; Tasaki, Toshiki; Tsujikawa, Tetsuya; Okazawa, Hidehiko; Imi, Tatsuya; Nannya, Yasuhito; Ogawa, Seishi; Nakao, Shinji.

Br J Haematol; 198(5): e75-e77, 2022 09.

Artículo en Inglés | MEDLINE | ID: mdl-35765195

19.

Management of infection during chemotherapy for acute leukemia in Japan: a nationwide questionnaire-based survey by the Japan Adult Leukemia Study Group.

Kimura, Shun-Ichi; Fujita, Hiroyuki; Kato, Hideaki; Hiramoto, Nobuhiro; Hosono, Naoko; Takahashi, Tsutomu; Shigeno, Kazuyuki; Hatsumi, Naoko; Minamiguchi, Hitoshi; Miyatake, Junichi; Handa, Hiroshi; Akiyama, Nobu; Kanda, Yoshinobu; Yoshida, Minoru; Kiyoi, Hitoshi; Miyazaki, Yasushi; Naoe, Tomoki.

Support Care Cancer; 25(11): 3515-3521, 2017 11.

Artículo en Inglés | MEDLINE | ID: mdl-28584934

20.

Lobar Hemorrhage Induced by Acquired Factor XIII Deficiency in a Patient with Cerebral Amyloid Angiopathy.

Arishima, Hidetaka; Neishi, Hiroyuki; Kikuta, Ken-Ichiro; Morita, Mihoko; Hosono, Naoko; Yamauchi, Takahiro; Souri, Masayoshi; Ichinose, Akitada.

J Stroke Cerebrovasc Dis; 26(10): e203-e205, 2017 Oct.

Artículo en Inglés | MEDLINE | ID: mdl-28801214

Portal de Búsqueda de la BVS España

Información y Conocimiento para la Salud

Configurar filtros

Su selección (0)

Formato de exportación:

Exportar:

Follow-up of patients with R/R FLT3-mutation-positive AML treated with gilteritinib in the phase 3 ADMIRAL trial.

[Future prospects for the development of novel agents for acute myeloid leukemia].

Clinical utility of genomic profiling of AML using paraffin-embedded bone marrow clots: HM-SCREEN-Japan 01.

Phase I study of alvocidib plus cytarabine/mitoxantrone or cytarabine/daunorubicin for acute myeloid leukemia in Japan.

Gilteritinib or Chemotherapy for Relapsed or Refractory FLT3-Mutated AML.

Mutated KIT Tyrosine Kinase as a Novel Molecular Target in Acute Myeloid Leukemia.

[Hematopoietic cell transplantation for FLT3-mutated acute myeloid leukemia].

Characterization of newly established Pralatrexate-resistant cell lines and the mechanisms of resistance.

Gilteritinib versus chemotherapy in Japanese patients with FLT3-mutated relapsed/refractory acute myeloid leukemia.

[Lineage switch from T-lymphoblastic leukemia to myeloid leukemia at relapse].

Venetoclax and alvocidib are both cytotoxic to acute myeloid leukemia cells resistant to cytarabine and clofarabine.

Genetic abnormalities and pathophysiology of MDS.

[Genetic defects of chromosome 5q and 7q in myeloid neoplasms].

[New therapeutic agents for acute myeloid leukemia].

Hematopoietic status of the whole-body bone marrow in hypoplastic acute promyelocytic leukemia as evaluated by ¹⁸F-FLT PET/MRI.

Infectious complications in adults undergoing intensive chemotherapy for acute myeloid leukemia in 2001-2005 using the Japan Adult Leukemia Study Group AML201 protocols.

[Evaluation of Chemotherapy-Induced Nausea and Vomiting in Patients with Hematological Malignancies Using MASCC Antiemesis Tool(MAT)].

An eltrombopag-induced remission of bone-marrow aplasia accompanied by marked leukoerythroblastosis and splenomegaly.

Management of infection during chemotherapy for acute leukemia in Japan: a nationwide questionnaire-based survey by the Japan Adult Leukemia Study Group.

Lobar Hemorrhage Induced by Acquired Factor XIII Deficiency in a Patient with Cerebral Amyloid Angiopathy.